In an unexpected move, PerkinElmer last week announced that it had acquired Spectral Genomics, a 6-year-old Houston company that sells products for array comparative genomic hybridization.

Having divested its semiconductor and fluid sciences businesses in recent months, PE now appears to be investing more in the molecular diagnostics space, a move that could equally benefit the position of Spectral Genomics' chips in the array CGH market.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.